FLEMINGTON, N.J., Jan. 3, 2018 /PRNewswire/ -- HCD Research has launched a consumer neuroscience business unit focusing on installing neuroscience laboratories in corporate testing facilities and supporting client efforts in leveraging neuroscience to optimize products. Lead by expert members Dr. Michelle Niedziela (neuroscientist, Director of Innovation & Technology) and Bill Thau (Director of Technology), this new business will help clients:
Plan and supply a consumer neuroscience research and testing capability at client sites
Identify technologies optimized for the specific requirements of consumer product R&D
Train staff on product optimization resulting from integration of consumer neuroscience
Recommend new neuroscience and marketing research technologies relevant to the client's product development efforts
Dr. Niedziela stated, "Applied consumer neuroscience, or neuromarketing, is permeating the consumer product industry and it is necessary to apply a variety of methodologies and services based on the research and development objectives of companies." For a number of organizations, HCD Research will execute projects from product inception to production and make recommendations towards product business decisions. For other segments of clients, we will help establish capabilities to allow companies to quickly collect data in their own facility and HCD will rapidly analyze neuroscience metrics and report to our clients.
HCD Research conducts combined consumer neuroscience and traditional methods worldwide. Since 2010 the company has pioneered methods for studying the subconscious response to product experience.
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.
Designed to address...
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...